Intelligence · Clinical Development
Pipeline search results
Programs matching “alcohol” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 117 pipeline programs matching "alcohol" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
AD04 (ondansetron)
ADIAL PHARMACEUTICALS, INC.
Alcohol Use Disorder
1 trial -
Aramchol free acid
Galmed Pharmaceuticals
Nonalcoholic Steatohepatitis (NASH)
1 trial -
Bias retraining
BRIGHT MINDS BIOSCIENCES INC.
Alcohol Use Disorder
1 trial -
C24-50
The George Institute
Semantic Variant Primary Progressive Aphasia, Alcohol Use Disorder, Organic amnesia syndrome, Narcolepsy, Alzheimer, Lewy Body Dementia
1 trial -
Eltrombopag
GlaxoSmithKline
Non-alcoholic Steatohepatitis
1 trial -
Gabapentin 300mg
BRIGHT MINDS BIOSCIENCES INC.
Alcohol Drinking
1 trial -
J2S-MC-GZME
Eli Lilly Co.
Alcohol Use Disorder
1 trial -
METHYLPREDNISOLONE , ACETYLCYSTEINE
The George Institute
Acute Alcoholic hepatitis
1 trial -
MGL-3196
Madrigal Pharmaceuticals EU Limited
NASH - Nonalcoholic Steatohepatitis
1 trial -
MGL-3196-11
Madrigal Pharmaceuticals EU Limited
Non-Alcoholic Steatohepatitis (NASH)
1 trial -
MGL-3196-19
Madrigal Pharmaceuticals EU Limited
Non-alcoholic Steatohepatitis (NASH) Cirrhosis
1 trial -
NN9931-4553
NovoThirteen
Non-alcoholic steatohepatitis (NASH)
1 trial -
Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Alcoholism
1 trial -
Placebo
Madrigal Pharmaceuticals EU Limited
Non-Alcoholic Fatty Liver Disease
1 trial -
Placebo
Tobira Therapeutics
Nonalcoholic Steatohepatitis
1 trial -
Progesterone
United Therapeutics Europe Ltd
Alcohol Dependence
1 trial -
Resmetirom
Madrigal Pharmaceuticals EU Limited
Non-Alcoholic Fatty Liver Disease
1 trial -
SIMFIB
The George Institute
Fibrosis liber, chronic liver disease, alcoholic liver disease
1 trial -
0.9% Sodium Chloride Injection
GlaxoSmithKline
Non-alcoholic Fatty Liver Disease
1 trial -
222291
GlaxoSmithKline
Liver Diseases, Alcoholic
1 trial -
30% Nitrous oxide
BRIGHT MINDS BIOSCIENCES INC.
Alcohol-Related Disorders
1 trial -
5 mg/kg CM-101
Chemomab Therapeutics
Nonalcoholic Steatohepatitis
1 trial -
ADX-629
Aldeyra Therapeutics
Alcohol Hepatitis
1 trial -
ARO-HSD Injection
Arrowhead Pharmaceuticals Ireland Limited
Non-alcoholic Steatohepatitis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.